Seeking AlphaTue, 09 Jun 2026 19:52:10 GMTNeurocrine Biosciences, Inc. (NBIX) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 TranscriptNBIX-1.81%
Seeking AlphaTue, 02 Jun 2026 17:51:52 GMTNeurocrine Biosciences, Inc. (NBIX) Presents at 46th Annual William Blair Growth Stock Conference TranscriptNBIX-1.81%
Investors Business DailyWed, 20 May 2026 16:39:44 GMTNeurocrine Biosciences Hits New Highs On Earnings SurgeNBIX-1.81%
Investors Business DailyFri, 15 May 2026 17:28:23 GMTCrowdStrike Leads This Group Of Four Stocks To New HighsNBIX-1.81%
Seeking AlphaTue, 12 May 2026 23:50:45 GMTNeurocrine Biosciences, Inc. (NBIX) Presents at Bank of America Global Healthcare Conference 2026 TranscriptNBIX-1.81%
Zacks Investment ResearchThu, 07 May 2026 17:45:21 GMTNeurocrine (NBIX) is an Incredible Growth Stock: 3 Reasons WhyNBIX-1.81%
Seeking AlphaWed, 06 May 2026 22:24:54 GMTNeurocrine Biosciences: Core Business On Track, Soleno Deal Adds Risky UpsideNBIX-1.81%
Seeking AlphaWed, 06 May 2026 02:31:15 GMTNeurocrine Biosciences, Inc. (NBIX) Q1 2026 Earnings Call TranscriptNBIX-1.81%
Zacks Investment ResearchTue, 05 May 2026 22:30:26 GMTNeurocrine (NBIX) Reports Q1 Earnings: What Key Metrics Have to SayNBIX-1.81%
Zacks Investment ResearchTue, 05 May 2026 22:16:16 GMTNeurocrine Biosciences (NBIX) Beats Q1 Earnings and Revenue EstimatesNBIX-1.81%
Zacks Investment ResearchThu, 30 Apr 2026 15:06:24 GMTEarnings Preview: Collegium Pharmaceutical (COLL) Q1 Earnings Expected to DeclineNBIX-1.81%
Zacks Investment ResearchTue, 28 Apr 2026 15:06:57 GMTNeurocrine Biosciences (NBIX) Reports Next Week: Wall Street Expects Earnings GrowthNBIX-1.81%
Zacks Investment ResearchTue, 21 Apr 2026 17:46:15 GMT3 Reasons Growth Investors Will Love Neurocrine (NBIX)NBIX-1.81%
Zacks Investment ResearchTue, 21 Apr 2026 14:57:16 GMTWall Street Analysts Think Neurocrine (NBIX) Could Surge 38.79%: Read This Before Placing a BetNBIX-1.81%
Zacks Investment ResearchWed, 15 Apr 2026 19:36:13 GMTIs the Options Market Predicting a Spike in Neurocrine Biosciences Stock?NBIX-1.81%
Seeking AlphaMon, 06 Apr 2026 15:32:07 GMTNeurocrine Biosciences, Inc. (NBIX) M&A Call TranscriptNBIX-1.81%
BarronsMon, 06 Apr 2026 11:24:00 GMTThis Pharma Stock Is Surging 40%. Neurocrine Is Buying It in $2.9 Billion Deal.NBIX-1.81%
Market WatchMon, 06 Apr 2026 11:04:00 GMTNeurocrine wants to develop new obesity drugs. It's reportedly nearing an acquisition to accelerate that move.NBIX-1.81%
Seeking AlphaTue, 17 Mar 2026 22:22:17 GMTNeurocrine Biosciences, Inc. (NBIX) Presents at Stifel 2026 Virtual CNS Forum TranscriptNBIX-1.81%
